Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

Dietary and Supplement-Based Complementary and Alternative Medicine Use in Pediatric Autism Spectrum Disorder.

Trudeau MS, Madden RF, Parnell JA, Gibbard WB, Shearer J.

Nutrients. 2019 Aug 1;11(8). pii: E1783. doi: 10.3390/nu11081783.

2.

Development of a questionnaire to assess dietary restrictions runners use to mitigate gastrointestinal symptoms.

Parnell JA, Lafave H, Wagner-Jones K, Madden RF, Erdman KA.

J Int Soc Sports Nutr. 2019 Feb 28;16(1):11. doi: 10.1186/s12970-019-0278-7.

3.

Impact of dietary fiber supplementation on modulating microbiota-host-metabolic axes in obesity.

Mayengbam S, Lambert JE, Parnell JA, Tunnicliffe JM, Nicolucci AC, Han J, Sturzenegger T, Shearer J, Mickiewicz B, Vogel HJ, Madsen KL, Reimer RA.

J Nutr Biochem. 2019 Feb;64:228-236. doi: 10.1016/j.jnutbio.2018.11.003. Epub 2018 Nov 26.

PMID:
30572270
4.

Evaluation of Dietary Supplement Use in Wheelchair Rugby Athletes.

Madden RF, Shearer J, Legg D, Parnell JA.

Nutrients. 2018 Dec 11;10(12). pii: E1958. doi: 10.3390/nu10121958.

5.

Histological improvement of non-alcoholic steatohepatitis with a prebiotic: a pilot clinical trial.

Bomhof MR, Parnell JA, Ramay HR, Crotty P, Rioux KP, Probert CS, Jayakumar S, Raman M, Reimer RA.

Eur J Nutr. 2019 Jun;58(4):1735-1745. doi: 10.1007/s00394-018-1721-2. Epub 2018 May 19.

PMID:
29779170
6.

Evaluation of Dietary Intakes and Supplement Use in Paralympic Athletes.

Madden RF, Shearer J, Parnell JA.

Nutrients. 2017 Nov 21;9(11). pii: E1266. doi: 10.3390/nu9111266.

7.

Oligofructose decreases serum lipopolysaccharide and plasminogen activator inhibitor-1 in adults with overweight/obesity.

Parnell JA, Klancic T, Reimer RA.

Obesity (Silver Spring). 2017 Mar;25(3):510-513. doi: 10.1002/oby.21763.

8.

Dietary Intake and Associated Body Weight in Canadian Undergraduate Students Enrolled in Nutrition Education.

Frehlich LC, Eller LK, Parnell JA, Fung TS, Reimer RA.

Ecol Food Nutr. 2017 May-Jun;56(3):205-217. doi: 10.1080/03670244.2017.1284066. Epub 2017 Feb 6.

PMID:
28166418
9.

Dietary Intakes and Supplement Use in Pre-Adolescent and Adolescent Canadian Athletes.

Parnell JA, Wiens KP, Erdman KA.

Nutrients. 2016 Aug 26;8(9). pii: E526. doi: 10.3390/nu8090526.

10.

Consuming yellow pea fiber reduces voluntary energy intake and body fat in overweight/obese adults in a 12-week randomized controlled trial.

Lambert JE, Parnell JA, Tunnicliffe JM, Han J, Sturzenegger T, Reimer RA.

Clin Nutr. 2017 Feb;36(1):126-133. doi: 10.1016/j.clnu.2015.12.016. Epub 2016 Jan 11.

PMID:
26811130
11.

Evaluation of congruence among dietary supplement use and motivation for supplementation in young, Canadian athletes.

Parnell JA, Wiens K, Erdman KA.

J Int Soc Sports Nutr. 2015 Dec 16;12:49. doi: 10.1186/s12970-015-0110-y. eCollection 2015.

12.

Gut microbiota manipulation with prebiotics in patients with non-alcoholic fatty liver disease: a randomized controlled trial protocol.

Lambert JE, Parnell JA, Eksteen B, Raman M, Bomhof MR, Rioux KP, Madsen KL, Reimer RA.

BMC Gastroenterol. 2015 Dec 3;15:169. doi: 10.1186/s12876-015-0400-5.

13.

The spinal stenosis pedometer and nutrition lifestyle intervention (SSPANLI): development and pilot.

Tomkins-Lane CC, Lafave LM, Parnell JA, Rempel J, Moriartey S, Andreas Y, Wilson PM, Hepler C, Ray HA, Hu R.

Spine J. 2015 Apr 1;15(4):577-86. doi: 10.1016/j.spinee.2014.10.015. Epub 2014 Oct 22.

PMID:
25452012
14.

Evaluation of yellow pea fibre supplementation on weight loss and the gut microbiota: a randomized controlled trial.

Lambert JE, Parnell JA, Han J, Sturzenegger T, Paul HA, Vogel HJ, Reimer RA.

BMC Gastroenterol. 2014 Apr 8;14:69. doi: 10.1186/1471-230X-14-69.

15.

Dietary supplement usage, motivation, and education in young, Canadian athletes.

Wiens K, Erdman KA, Stadnyk M, Parnell JA.

Int J Sport Nutr Exerc Metab. 2014 Dec;24(6):613-22. doi: 10.1123/ijsnem.2013-0087. Epub 2014 Mar 25.

PMID:
24667342
16.

The spinal stenosis pedometer and nutrition lifestyle intervention (SSPANLI) randomized controlled trial protocol.

Tomkins-Lane CC, Lafave LM, Parnell JA, Krishnamurthy A, Rempel J, Macedo LG, Moriartey S, Stuber KJ, Wilson PM, Hu R, Andreas YM.

BMC Musculoskelet Disord. 2013 Nov 14;14:322. doi: 10.1186/1471-2474-14-322.

17.

Prebiotic fiber modulation of the gut microbiota improves risk factors for obesity and the metabolic syndrome.

Parnell JA, Reimer RA.

Gut Microbes. 2012 Jan-Feb;3(1):29-34. doi: 10.4161/gmic.19246. Review.

18.

The potential role of prebiotic fibre for treatment and management of non-alcoholic fatty liver disease and associated obesity and insulin resistance.

Parnell JA, Raman M, Rioux KP, Reimer RA.

Liver Int. 2012 May;32(5):701-11. doi: 10.1111/j.1478-3231.2011.02730.x. Epub 2011 Dec 30. Review.

PMID:
22221818
19.

Prebiotic fibres dose-dependently increase satiety hormones and alter Bacteroidetes and Firmicutes in lean and obese JCR:LA-cp rats.

Parnell JA, Reimer RA.

Br J Nutr. 2012 Feb;107(4):601-13. doi: 10.1017/S0007114511003163. Epub 2011 Jul 18.

20.

Effect of prebiotic fibre supplementation on hepatic gene expression and serum lipids: a dose-response study in JCR:LA-cp rats.

Parnell JA, Reimer RA.

Br J Nutr. 2010 Jun;103(11):1577-84. doi: 10.1017/S0007114509993539. Epub 2009 Dec 21.

Supplemental Content

Loading ...
Support Center